Primary Site >> Liver Cancer
Gene >> MYLK
|
|
|
|
|---|---|---|---|
|
Ref: MR-1 modulates proliferation and migration of human hepatoma HepG2 cells through myosin light chains-2 (MLC2)/focal adhesion kinase (FAK)/Akt signaling pathway. PMID: 18948272 |
Ref: Resveratrol down-regulates Myosin light chain kinase, induces apoptosis and inhibits diethylnitrosamine-induced liver tumorigenesis in rats. PMID: 23344064 |
Ref: Matrine inhibits diethylnitrosamine-induced HCC proliferation in rats through inducing apoptosis via p53, Bax-dependent caspase-3 activation pathway and down-regulating MLCK overexpression. PMID: 27642320 Ref: Genomic characterization of liver metastases from colorectal cancer patients. PMID: 27662660 |
Ref: Fenretinide inhibits the proliferation and migration of human liver cancer HepG2 cells by downregulating the activation of myosin light chain kinase through the p38MAPK signaling pathway. PMID: 29767236 Ref: MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial-mesenchymal transition. PMID: 29855744 |